PR PolyResearch

Join Free

NASDAQ

Amphastar Pharmaceuticals, Inc. (AMPH)

♥ 357 Thanks from members

Amphastar Pharmaceuticals, Inc. (AMPH) exhibits mixed market sentiment, balancing product pipeline progress and stable revenues against compressed gross margins, insider selling, and lowered analyst price targets.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)